AR015485A1 - Una capsula oral tragable que contiene paroxetina, una forma solida de dosificacion oral tragable, una formulacion farmaceutica, una procedimiento parapreparar dicha formulacion y la utilizacion de paroxetina disuelta en un vehiculo para fabricar capsulas o formas solidas de dosificacion orales trag - Google Patents
Una capsula oral tragable que contiene paroxetina, una forma solida de dosificacion oral tragable, una formulacion farmaceutica, una procedimiento parapreparar dicha formulacion y la utilizacion de paroxetina disuelta en un vehiculo para fabricar capsulas o formas solidas de dosificacion orales tragInfo
- Publication number
- AR015485A1 AR015485A1 ARP980105880A ARP980105880A AR015485A1 AR 015485 A1 AR015485 A1 AR 015485A1 AR P980105880 A ARP980105880 A AR P980105880A AR P980105880 A ARP980105880 A AR P980105880A AR 015485 A1 AR015485 A1 AR 015485A1
- Authority
- AR
- Argentina
- Prior art keywords
- paroxetine
- formulation
- solid
- vehicle
- dissolved
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Una cápsula oral tragable y una forma solida de dosificacion oral tragable de paroxetina en las que la paroxetina está en disolucion en un vehículosolido, semisolido o líquido. Las disoluciones se utilizan para rellenar cápsulas, o si se trata de disoluciones solidas auto-soportantes se moldean en formassolidas de dosificacion tales como tabletas o perlas. También se describen nuevas formulaciones líquidas en las que se utiliza un agente solubilizantepra solubilizar paroxetina en aceites y/o lípidos, para evitar otras formas de paroxetina que se convierten en el hemihidrato, por utilizacion de vehículoso excipientes anhidros o hidrofobos. Además se describe un procedimiento para preparar dicha formulacion y la utilizacion de paroxetina disuelta en unvehículo para fabricar cápsulas o formas solidas de dosificacion orales tragables para el tratamiento y/o profilaxis de uno o más trastornos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9724544.3A GB9724544D0 (en) | 1997-11-21 | 1997-11-21 | Novel Formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
AR015485A1 true AR015485A1 (es) | 2001-05-02 |
Family
ID=10822374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980105880A AR015485A1 (es) | 1997-11-21 | 1998-11-19 | Una capsula oral tragable que contiene paroxetina, una forma solida de dosificacion oral tragable, una formulacion farmaceutica, una procedimiento parapreparar dicha formulacion y la utilizacion de paroxetina disuelta en un vehiculo para fabricar capsulas o formas solidas de dosificacion orales trag |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1033986A1 (es) |
JP (1) | JP2001523718A (es) |
KR (1) | KR20010032320A (es) |
CN (1) | CN1279608A (es) |
AP (1) | AP2000001821A0 (es) |
AR (1) | AR015485A1 (es) |
AU (1) | AU1168099A (es) |
BG (1) | BG104527A (es) |
BR (1) | BR9814220A (es) |
CO (1) | CO4970832A1 (es) |
DZ (1) | DZ2658A1 (es) |
EA (1) | EA200000552A1 (es) |
GB (1) | GB9724544D0 (es) |
HU (1) | HUP0100580A3 (es) |
IL (1) | IL136106A0 (es) |
MA (1) | MA24704A1 (es) |
NO (1) | NO20002590L (es) |
OA (1) | OA11385A (es) |
PE (1) | PE20000381A1 (es) |
PL (1) | PL340555A1 (es) |
SK (1) | SK7342000A3 (es) |
TR (1) | TR200001423T2 (es) |
WO (1) | WO1999026625A1 (es) |
ZA (1) | ZA9810637B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9810180D0 (en) * | 1998-05-13 | 1998-07-08 | Smithkline Beecham Plc | Novel formulation |
CA2367402C (en) * | 1999-03-12 | 2010-11-23 | Basf Aktiengesellschaft | Stable pharmaceutical dosage form for paroxetine anhydrate |
WO2001002393A1 (en) | 1999-07-01 | 2001-01-11 | Italfarmaco S.P.A. | Complexes of paroxetine, with cyclodextrins or cyclodextrin derivatives |
DE19930454A1 (de) * | 1999-07-02 | 2001-01-04 | Knoll Ag | Feste Paroxetin enthaltende Zubereitungen |
US6720003B2 (en) | 2001-02-16 | 2004-04-13 | Andrx Corporation | Serotonin reuptake inhibitor formulations |
ES2294197T3 (es) * | 2001-12-21 | 2008-04-01 | Supernus Pharmaceuticals, Inc. | Formulacion de capsula oral con estabilidad fisica aumentada. |
SE0200475D0 (sv) * | 2002-02-15 | 2002-02-15 | Ltp Lipid Technologies Provide | Oral farmaceutisk beredning |
WO2006119779A2 (en) * | 2005-05-10 | 2006-11-16 | Lifecycle Pharma A/S | A pharmaceutical composition comprising an aldosterone antagonist in form of solid solution |
US20120322752A1 (en) * | 2009-12-08 | 2012-12-20 | Sung Kyun Lee | SOLID DISPERSIONS CONTAINING 20-O-beta-D-GLUCOPYRANOSYL-20(S)-PROTOPANAXADIOL |
GB201020032D0 (en) * | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
CN103961333B (zh) * | 2014-05-07 | 2020-02-21 | 浙江华海药业股份有限公司 | 甲磺酸帕罗西汀胶囊及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996031197A1 (en) * | 1995-04-03 | 1996-10-10 | Abbott Laboratories | Homogeneous mixtures of low temperature-melting drugs and additives for controlled release |
HUP0000960A3 (en) * | 1997-01-15 | 2001-04-28 | Smithkline Beecham Plc | Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same |
-
1997
- 1997-11-21 GB GBGB9724544.3A patent/GB9724544D0/en not_active Ceased
-
1998
- 1998-11-18 CN CN98811404A patent/CN1279608A/zh active Pending
- 1998-11-18 WO PCT/GB1998/003471 patent/WO1999026625A1/en not_active Application Discontinuation
- 1998-11-18 PE PE1998001126A patent/PE20000381A1/es not_active Application Discontinuation
- 1998-11-18 EP EP98954631A patent/EP1033986A1/en not_active Withdrawn
- 1998-11-18 PL PL98340555A patent/PL340555A1/xx unknown
- 1998-11-18 TR TR2000/01423T patent/TR200001423T2/xx unknown
- 1998-11-18 AP APAP/P/2000/001821A patent/AP2000001821A0/en unknown
- 1998-11-18 KR KR1020007005532A patent/KR20010032320A/ko not_active Application Discontinuation
- 1998-11-18 SK SK734-2000A patent/SK7342000A3/sk unknown
- 1998-11-18 BR BR9814220-8A patent/BR9814220A/pt not_active Application Discontinuation
- 1998-11-18 JP JP2000521827A patent/JP2001523718A/ja active Pending
- 1998-11-18 DZ DZ980268A patent/DZ2658A1/xx active
- 1998-11-18 IL IL13610698A patent/IL136106A0/xx unknown
- 1998-11-18 HU HU0100580A patent/HUP0100580A3/hu unknown
- 1998-11-18 AU AU11680/99A patent/AU1168099A/en not_active Abandoned
- 1998-11-18 EA EA200000552A patent/EA200000552A1/ru unknown
- 1998-11-19 MA MA25357A patent/MA24704A1/fr unknown
- 1998-11-19 AR ARP980105880A patent/AR015485A1/es unknown
- 1998-11-20 ZA ZA9810637A patent/ZA9810637B/xx unknown
- 1998-11-20 CO CO98068459A patent/CO4970832A1/es unknown
-
2000
- 2000-05-19 NO NO20002590A patent/NO20002590L/no not_active Application Discontinuation
- 2000-05-19 OA OA1200000153A patent/OA11385A/en unknown
- 2000-06-13 BG BG104527A patent/BG104527A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BG104527A (en) | 2001-04-30 |
AU1168099A (en) | 1999-06-15 |
OA11385A (en) | 2004-01-27 |
MA24704A1 (fr) | 1999-07-01 |
ZA9810637B (en) | 2000-05-22 |
DZ2658A1 (fr) | 2003-03-22 |
BR9814220A (pt) | 2001-12-26 |
EP1033986A1 (en) | 2000-09-13 |
HUP0100580A2 (hu) | 2002-04-29 |
NO20002590D0 (no) | 2000-05-19 |
PL340555A1 (en) | 2001-02-12 |
PE20000381A1 (es) | 2000-05-07 |
NO20002590L (no) | 2000-07-19 |
EA200000552A1 (ru) | 2000-10-30 |
TR200001423T2 (tr) | 2000-10-23 |
JP2001523718A (ja) | 2001-11-27 |
SK7342000A3 (en) | 2000-12-11 |
CN1279608A (zh) | 2001-01-10 |
CO4970832A1 (es) | 2000-11-07 |
IL136106A0 (en) | 2001-05-20 |
WO1999026625A1 (en) | 1999-06-03 |
HUP0100580A3 (en) | 2002-05-28 |
GB9724544D0 (en) | 1998-01-21 |
KR20010032320A (ko) | 2001-04-16 |
AP2000001821A0 (en) | 2000-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR015485A1 (es) | Una capsula oral tragable que contiene paroxetina, una forma solida de dosificacion oral tragable, una formulacion farmaceutica, una procedimiento parapreparar dicha formulacion y la utilizacion de paroxetina disuelta en un vehiculo para fabricar capsulas o formas solidas de dosificacion orales trag | |
US20030104048A1 (en) | Pharmaceutical dosage forms for highly hydrophilic materials | |
BR9916224A (pt) | Forma de dosagem farmacêutica oral, processos para a manufatura de uma forma de dosagem fixa, para o tratamento e a profilaxia de distúrbios gastrintestinais e para evitar efeitos colaterias gastrintestinais, uso de uma forma de dosagem, combinação, e, embalagem tipo ampola | |
AR006652A1 (es) | Forma farmacéutica de dosificación oral para el tratamiento oral de enfermedades óseas. | |
JP2020506918A (ja) | 特定の胃腸部位での制御放出の剤形 | |
ES2187822T3 (es) | Comprimidos de disgregacion rapida. | |
RU2012102772A (ru) | Фармацевтическая таблетка, содержащая заполненную жидкостью капсулу | |
CO4940409A1 (es) | Tableta cubierta con pelicula para seguridad mejorada del tracto gastrointestinal superior | |
PA8509001A1 (es) | Forma de dosificacion de farmacos accionada por un hidrogel | |
ECSP034826A (es) | Método para fabricar una composición farmacéutica de dosis baja | |
EA200700158A1 (ru) | Лекарственные формы с ядром таблетки, покрытым энтеросолюбильной оболочкой | |
AR011919A1 (es) | FORMULACIoN EN COMPRIMIDOS O CÁPSULAS PARA TRAGAR DE PARACETAMOL (N-ACETIL-P-AMINOFENOL) Y PROCEDIMIENTO PARA PREPARARLA | |
BRPI0417938A (pt) | formulações de proteìnas hidrofóbicas em uma composição imunogênica que possui tolerabilidade aperfeiçoada | |
AR037560A1 (es) | Formulacion de altas dosis de ibandronato | |
JP2023078155A (ja) | 剤形およびそれらの使用 | |
BR0210224A (pt) | Formas de dosagem projetada para ser engolida diretamente e apresentada como uma formulação em comprimido ou cápsula deglutìvel, e, processo para preparação de uma forma de dosagem | |
MXPA06008241A (es) | Composicion dermatologica de gel suave. | |
BR0115989A (pt) | Preparação farmacêutica na forma de uma suspensão compreendendo um ingrediente ativo instável a ácido | |
CN105142596A (zh) | 用于治疗口腔干燥和用于牙齿治疗的组合物 | |
JPH02157220A (ja) | 徐放性坐剤 | |
AR013261A1 (es) | Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina | |
HUT62471A (en) | Process for producing pharmaceutical compositions comprising ipriflavone | |
RU2003105601A (ru) | Лекарственный препарат, предназначенный для лечения сексуальных расстройств | |
ES2935528T3 (es) | Formulación y suspensión oral de un fármaco oncológico | |
AR043412A1 (es) | Formulaciones farmaceuticas que comprenden un agente enmascarante del sabor amargo |